Omalizumab prevents anaphylactoid reactions to mRNA COVID‐19 vaccine. (10th August 2021) - Smola, A.; Samadzadeh, S.; Müller, L.; Adams, O.; Homey, B.; Albrecht, P.; Meller, S.